Fred Poordad, University of Texas Health Science Center at San Antonio (IMAGE)

University of Texas Health Science Center at San Antonio

Fred Poordad, University of Texas Health Science Center at San Antonio

Caption

Fred Poordad, M.D., of the UT Health Science Center San Antonio and Texas Liver Institute led the ALLY-1 trial. The overall cure rate for Hepatitis C patients with a liver transplant was 94 percent and 83 percent for patients with advanced cirrhosis.

Credit

Texas Liver Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.